Guidelines support the use of bridging therapy for UNOS Stage T2 lesions if the wait time is expected to be six months or ...

Stage 3 or 4 fibrosis is associated with a risk ... 3 Dr. Dudzinski: Surveillance abdominal ultrasonography for hepatocellular carcinoma was performed at the third hospital at 12-month intervals.

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for ...

The FDA has granted approval to nivolumab plus ipilimumab for use in unresectable or metastatic hepatocellular carcinoma.

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

Advanced hepatocellular carcinoma (HCC) with pulmonary metastasis (PM) has a poor prognosis, and optimal treatment strategies remain controversial. This study compared pulmonary metastasectomy and ...